Mersana Therapeutics
MRSN
MRSN
113 hedge funds and large institutions have $219M invested in Mersana Therapeutics in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 120 → 113 (-7)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
37% less call options, than puts
Call options by funds: $770K | Put options by funds: $1.23M
Holders
113
Holding in Top 10
1
Calls
$770K
Puts
$1.23M
Top Buyers
| 1 | +$4.8M | |
| 2 | +$3.43M | |
| 3 | +$3.15M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$2.44M |
| 5 |
EAM
Exome Asset Management
New York
|
+$2.23M |
Top Sellers
| 1 | -$5.23M | |
| 2 | -$1.95M | |
| 3 | -$1.81M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.73M |
| 5 |
Morgan Stanley
New York
|
-$1.72M |